<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="370512">
  <stage>Registered</stage>
  <submitdate>14/04/2016</submitdate>
  <approvaldate>19/05/2016</approvaldate>
  <actrnumber>ACTRN12616000653460</actrnumber>
  <trial_identification>
    <studytitle>LEAP-CP: Learning through Everyday Activities with Parents for infants at high risk of Cerebral Palsy in a low-income country</studytitle>
    <scientifictitle>Community-based parent delivered early detection and intervention program for infants at high risk of cerebral palsy in a low-resource setting: a randomised controlled trial</scientifictitle>
    <utrn />
    <trialacronym>LEAP-CP</trialacronym>
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>cerebral palsy</healthcondition>
    <conditioncode>
      <conditioncode1>Physical Medicine / Rehabilitation</conditioncode1>
      <conditioncode2>Other physical medicine / rehabilitation</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The LEAP-CP intervention is a multidisciplinary family-centred intervention comprising of 2 parts; (1) delivered peer to peer in the home during 15 fortnightly 2-hour visits (over a 7-10 month period, allowing for missed visits due to illness and family/ religious events); (2) delivered by the caregiver to the infant daily (based on the games/ strategies delivered in the fortnightly peer to peer visit. 

During the fortnightly visit, the Community Disability Worker (peer trainer) will (i) gather feedback and troubleshoots the previous fortnights activities, (ii) deliver the therapeutic modules, (iii) deliver the educational module. The caregiver will be provided with written and pictographic information of the three modules each fortnight to facilitate their use of the strategies each day during the upcoming fortnight. 

Therapeutic Modules:
The therapeutic modules are first modeled with the infant by the CDW, and then the caregiver encouraged to engage with their infant, with CDW coaching. The therapeutic modules consist of:
1.	Multidimensional activity based curriculum for infants aged 3-18 months, based on the Creative Curriculum Learning Games (Sparling &amp; Lewis 2008) as a framework for structure and approach. Culturally modified activity cards are translated into Bengali, and include pictographic prompts for how to make this game easier and how to encourage practice in other situations. The CDW will present four activity cards to the caregiver each fortnight from which the caregiver selects two to learn and deliver with their infant during the fortnight (total of 30 games for the program duration). The four options will be selected based on the infants age and developmental stage, with guidance from the Community Coordinator. The literature highlights the importance of collaborative selection of therapeutic activities. When delivering a game, the CDW ensures that the infant can complete at least part of the task actively, to ensure optimal motor learning. 
2.	Individualised goal-directed module: Specific goal-based strategies will be introduced using strategy sheets developed for the study by a multidisciplinary team of clinicians specialised in cerebral palsy (physiotherapy, occupational therapy, speech pathology, psychology and physician).  Caregivers will be supported to choose a self-generated intervention goal in visit number 2, individualised to their infant. Each goal area includes red flags for referral for complex and high risk presentations. As a goal is achieved, caregivers will be encouraged to choose a new goal. If the infant remains on a goal without progress for greater than 4 visits (2 months), caregivers will be encouraged to choose a new goal.

Parent Educational Modules (one per fortnight):
Module 1. Building rapport and program overview (Novak 2006) 
-	Introduction of CDW, caregiver and infant
-	Building rapport and general observation of preferred play activity
-	What does the LEAP/ SC program cover (frequency of visits, content)

Module 2. Setting goals and problem solving  approach (Novak 2006) 
-	Identify infant and family strengths/ abilities
-	Discuss caregivers needs and priorities for their infant and family (development and care)
-	Goal setting with the COPM
-	Introduction of a problem solving approach and caregiver coaching

Module 3. Living a meaningful life (Whittingham 2013, 2014) 	
-	Dealing with grief
-	Finding hope to live a meaningful life
-	Parent self-care

Module 4. Breastfeeding (WHO 1993) 
-	Importance of exclusive breastfeeding
-	What is optimal breastfeeding
-	Observation of a feed (with support strategies)

Module 5. Parent-infant bonding and interaction (Care for Child Development modules; Whittingham 2013, 2014)	
-	Increasing caregivers awareness of infant movements and behaviours (reading their cues)
-	Building a warm connection between caregiver and infant
-	Responding consistently and positively to the infant (praise and advise the caregiver on care practices)

Module 6. Encouraging your babys active and independent play (Law 2011) 	
-	Importance of infant being active in task engagement.
-	How to encourage active play: activity selection (just right challenge) and providing appropriate physical support  and cues

Module 7. Introduction of complementary feeding (WHO 2004) 
-	Importance of complementary feeding
-	Family beliefs and community practices
-	Preparing safe and nutritious early foods
-	Foods for energy and specific nutrients 
-	Observation of a snack (with support strategies)

Module 8. Infant health (WHO, 2014) 	
-	Reflux: signs, basic management and when to seek help
-	Epilepsy: signs and when to seek help
-	Diarrhoeal disease: basic management and when to seek help
-	Other common health concerns and health seeking behaviour

Module 9. Growth monitoring (WHO 2009) 
-	Growth measures
-	24 hour recall of dietary intake
-	Counselling regarding recommended daily intake (food groups).

Module 10. Adding repetition and variability to your babys play (Fetters 2010) 	
-	Building on parent observation skills
-	Moving and sitting
-	How to set up the infants environment to encourage repetition and variable practice
-	How much variability is beneficial to learning, and how much is too much?

Module 11. Creating enriched environments to encourage independent play (Morgan 2013) 
-	How to create an enriched environment at home, using home-based objects and toys
-	Choosing the right toy for the right skill
-	Using hands for reaching
-	Making home-made toys

Module 12. Responding to your babys cues and communication (Pepper &amp; Weitzman 2004)
-	Child lead interaction
-	Observe, Wait, Listen
-	Adding language to interaction
-	Creating communication opportunities

Module 13. Finding joy in your baby (Whittingham 2013, 2014)	
-	Creating space for positive emotions with your baby: mindfulness
-	Become an accepting space for your baby

Module 14. Sharing books with your baby (Pepper &amp; Weitzman 2004)
-	Why reading is important, even with babies
-	How to read (with and without literacy)
-	Making your own books
Module 15. Connecting with your community (Nakamanya 2015, Whittingham 2015) 
-	CDW discusses feasibility of facilitating a local parent support network with other mothers in the program.
-	Maximising social support from family and friends 
-	Exploring connection to universal services in the community, such as playgroups.
-	Access to health and therapy services.

Dose: The overall dose delivered directly to the infant will be 104.2 hours for the 15 fortnight intervention. The overall dose delivered to the caregiver will be 30 hours (2 hours per fortnight). The infant intervention dose is a combination of:
(1) the intervention delivered to the infant during the CDW visit with the caregiver and infant (1 hour per fortnight, to a total program dose of 15 hours. While the CDW visit is for 2 hours in duration, 1 hour will be parent education which is not included in the direct infant intervention dose);
(2) the intervention delivered daily by the caregiver (which is graded with infant age as follows). The caregiver delivered intervention will commence at 3-6 months C.A. at a dose of 20 minutes per day for 5 days per week (1.6 hours) up to 6 months C.A. (total dose 19.2 hours); then graduate to 30 minutes per day for 5 days per week (2.5 hours per week) from 6-9 months C.A. (total 30 hours); then 40 minutes per day for 5 days per week (3.3 hours per week) from 9-12 months C.A. (total 40 hours).  

Service Delivery with Community Disability Workers (CDW)
A caregiver enrolled in the intervention will be trained as a Community Disability Worker (CDW) to deliver the intervention (peer to peer). One caregiver will be employed as a CDW for each community cluster (approximately six infants). They will receive a five day training package at the onset of the program (with the Chief Investigator, an Australian Post-doctoral fellow and speech pathologist). This will include topics such as:
-	Building rapport and a positive therapeutic relationship with caregivers
-	Exploring customs, beliefs and family culture
-	Using everyday opportunities and routines to encourage infant development
-	Observation skills and coaching
-	Motor training and therapeutic principles
-	Understanding typical development and development in cerebral palsy.
-	Ethics and research practices

CDWs will also receive training for 3 hours each fortnight with the Community Coordinator (Bangladesh trained therapist or allied health professional) to support them in the specific content of the program (therapeutic and educational modules). During this fortnightly session, they will also have opportunity for supervision, debriefing, and troubleshooting.

Concurrent therapies: Any concurrent therapies provided to the infants in either arm of the study will be recorded by the CDW on the HRU form during their fortnightly visit.

Adverse events: Any adverse events associated with the program will be screened at 6 and 12 months using open-ended questions by non-treating personnel.

Fidelity: Intervention dose will be measured by (1) token counting; (2) videoed activities; (3) CDW feedback. Two fortnights per caregiver will be randomly selected to estimate the frequency the caregiver applies the intervention strategies. Caregivers are asked to put a token in the jar for every 10 minute interaction with their infant, to estimate the total fortnightly interaction time. Caregivers with literacy will complete a paper version. In addition, 10 minutes of interaction will be videoed by the CDW to quantify the use of the previous fortnights strategies by the caregiver. The CDW will also record feedback from the caregiver, including successes and challenges to implementation. Frequency and duration of access to local therapy services will be recorded fortnightly on the Health Resource Use Form, and included in the analysis.</interventions>
    <comparator>The control group will receive 15 fortnightly visits from a different CDW, delivering standard care based on the World Health Organisation Integrated Management of Childhood Illness: Key Family Practices'. This includes counselling on breastfeeding and introduction of complementary nutrition, hygiene practices, immunisation counselling, and management of the sick child. </comparator>
    <control>Active</control>
    <interventioncode>Rehabilitation</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Infant functional abilities: change in normative standard scores on the Pediatric Evaluation of Disability Inventory- Computer Adaptive Test (PEDI-CAT)</outcome>
      <timepoint>Baseline, and post-intervention (18 months CA)</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Caregiver mental health: change in scores on the Depression, Anxiety, Stress Scale  Short Form (DASS) </outcome>
      <timepoint>Baseline, and post-intervention (infant aged 18 months CA)</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Infant goal attainment: Canadian Occupational Performance Measure (COPM): only completed for the intervention arm</outcome>
      <timepoint>Baseline, and post-intervention (18 months CA)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Infant cognitive development: Bayley Scales of Infant Development III (BSID-III)</outcome>
      <timepoint>Baseline, and post-intervention (18 months CA)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Infant nutritional status: Weight, to the nearest 100g (converted into Z scores based on WHO guidelines)</outcome>
      <timepoint>Baseline, fortnight 8 of intervention, and post-intervention (18 months CA)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Health resource use, recorded on Health Resource Use Form (Boyd 2013)</outcome>
      <timepoint>Baseline, and post-intervention (18 months CA)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Infant motor skills: Peabody Developmental Motor Scales - Second edition (PDMS-2)</outcome>
      <timepoint>Baseline, and post-intervention (18 months CA)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Infant nutritional status: Height/ length to nearest completed millimetre (converted into Z scores according to WHO guidelines)</outcome>
      <timepoint>Baseline, fortnight 8 of intervention, and post-intervention (18 months CA)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Infant nutritional status: Body Mass Index Z score (WHO guidelines)</outcome>
      <timepoint>Baseline, fortnight 8 of intervention, and post-intervention (18 months CA)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Infant nutritional status: Head circumference, to nearest completed millimetre</outcome>
      <timepoint>Baseline, fortnight 8 of intervention, and post-intervention (18 months CA)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Infant nutritional status: Mean upper arm circumference, to nearest completed millimetre</outcome>
      <timepoint>Baseline, fortnight 8 of intervention, and post-intervention (18 months CA)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Infant neurological status: Hammersmith Infant Neurological Examination (HINE)</outcome>
      <timepoint>Baseline (if not completed as part of eligibility assessment), and post-intervention (18 months CA)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality and extent of stimulation in the home: HOME Inventory</outcome>
      <timepoint>Baseline, and post-intervention (18 months CA)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Infants must live in one of the study geographical areas, be aged 12-40 weeks C.A. and be diagnosed with cerebral palsy (CP) or assessed to be at high risk of cerebral palsy. Eligibility assessments will be videoed by the community coordinator and scored by certified General Movements (GMs) assessors. Infants will be determined at risk if:
- Aged 12-17 weeks corrected age (CA) with absent fidgety movements on the GMs assessment (98% predictive of CP). GMs is a feasible assessment in this context as it can be videoed by the community coordinator and scored by a general movements certified rater.
- Aged 18-40 weeks CA and score as abnormal on the Hammersmith Infant Neurological Examination (90% predictive of CP)</inclusivecriteria>
    <inclusiveminage>12</inclusiveminage>
    <inclusiveminagetype>Weeks</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Weeks</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Infants will be excluded from the study if diagnosed with a neurodegenerative condition or presenting with uncontrolled seizures.

There are no exclusion criteria for parents</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>The clinician completing the eligibility assessment will be unaware of the group allocation. Eligibility assessments will be completed by Associate Investigators, and eligible infant codes sent to the CIA off-site who will hold the allocation schedule (based on a random computer generated sequence).</concealment>
    <sequence>Simple randomisation based on computer generated sequences.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Sample size:
The primary hypothesis is that the community-based intervention will improve childrens normative standard scores on the PEDI-CAT at 12 months by 0.5SD compared to standard care. A sample size of 64 children per group will be required to detect this change (alpha=0.05, beta=0.8). Assuming 10% attrition during the year, this would equate to 71 children per group (total recruitment n=142). 
Analysis:
Descriptive statistics (frequencies, means and 95% confidence intervals) will be used to describe each of the samples (at baseline and post-intervention). Intention to treat analysis will be used to compare outcomes post-intervention, using the PEDI-CAT as the primary outcome measure. Between-group differences on the PEDI-CAT normative standard score (continuous data) will be compared using multivariate linear regression, adjusting for differences between sample characteristics (eg. age, gender, epilepsy, GMFCS, motor type, preterm status, socioeconomic status). Secondary analyses will consider gains on motor or cognitive outcomes (PDMS-2, BSID-III), caregiver outcomes and health economics. All analyses will be conducted using STATA 13, with significance set at p&lt;0.05.</statisticalmethods>
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/10/2016</anticipatedstartdate>
    <actualstartdate>13/03/2017</actualstartdate>
    <anticipatedenddate>31/01/2018</anticipatedenddate>
    <actualenddate />
    <samplesize>142</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Bangladesh</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>West Bengal</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Queensland Cerebral Palsy and Rehabilitation Research Centre, The University of Queensland</primarysponsorname>
    <primarysponsoraddress>Centre for Child Health Research
Level 6, 62 Graham St
South Brisbane Qld 4101</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Queen Elizabeth II Diamond Jubilee Scholarship, Endeavour, Australian Government (directly administered scholarship)</fundingname>
      <fundingaddress>Department of Education and Training
International Group
International Mobility Branch
Endeavour Scholarships and Fellowships
GPO Box 9880
CANBERRA ACT 2601
AUSTRALIA</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Cerebral Palsy Alliance Research Foundation</fundingname>
      <fundingaddress>187 Allambie Rd, Allambie Heights, NSW 2100
PO Box 6427, Frenchs Forest, NSW 2086</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Apollo Gleneagles Hosptial, Kolkata</sponsorname>
      <sponsoraddress>58, Canal Circular Rd
Kadapara, Kolkata, West Bengal 700054
India</sponsoraddress>
      <sponsorcountry>India</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>One in seven people globally has a disability, forming the worlds largest and most disadvantaged minority. Cerebral palsy (CP) is the most common cause of childhood disability, with 80% of the estimated global burden in low and middle income countries (LMIC). The current state of evidence allows reliable prediction of infants at risk of CP from 13 weeks, however children in LMIC typically do not receive their diagnosis until 5 years. This means we are missing a significant window of opportunity for treatment when infants neuroplasticity is optimal. 

This study aims to determine the effectiveness of an early detection and intervention program for infants at high risk of CP in a low income country. This is a cluster-randomised double blind controlled trial of 142 high risk infants living in South Asia (inclusion criteria: absent fidgety General Movements at 12-17 weeks, or abnormal score on the Hammersmith Infant Neurological Evaluation at 18-26 weeks). Infants are randomised into a community-based parent-delivered 'best practice' intervention (15 fortnights of enriched environment (based on the Learning Games curriculum, demonstrated effective in over 16 RCTs); goal-directed motor training; and parent education, including nutrition, parenting and health) versus standard care (based on the Integrated Management of Childhood Illness). The intervention will be conducted through a train the trainer model, based on the highly effective lay health worker model, to ensure long-term sustainability. Primary functional outcomes will be measured at 18 months using the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test. It is hypothesised that children receiving the intervention will have improved motor and cognitive outcomes, and caregivers to have improved mental health. This program presents a feasible, transposable and scalable model which, if shown to be effective, has the potential to reduce the burden of disability in LMICs.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Childrenâ€™s Health Services Human Research Ethics Committee</ethicname>
      <ethicaddress>Childrens Health Queensland
Level 7, Centre for Childrens Health Research
62 Graham Street
South Brisbane QLD 4101</ethicaddress>
      <ethicapprovaldate>5/07/2016</ethicapprovaldate>
      <hrec>HREC/16/QRCH/214</hrec>
      <ethicsubmitdate>6/06/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>The University of Queensland Human Ethics</ethicname>
      <ethicaddress />
      <ethicapprovaldate>15/08/2016</ethicapprovaldate>
      <hrec>2016001073</hrec>
      <ethicsubmitdate>1/07/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Bangladesh Medical Research Council</ethicname>
      <ethicaddress>BMRC Bhaban, 
Mohakhali, Dhaka-1212</ethicaddress>
      <ethicapprovaldate>4/10/2016</ethicapprovaldate>
      <hrec>BMRC/NREC/2016-2019/1564</hrec>
      <ethicsubmitdate>6/06/2016</ethicsubmitdate>
      <ethiccountry>Bangladesh</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Apollo Gleneagles Hospital Human Research Ethics</ethicname>
      <ethicaddress>58, Canal Circular Rd
Kadapara, Kolkata, West Bengal 700054
India</ethicaddress>
      <ethicapprovaldate>3/12/2016</ethicapprovaldate>
      <hrec>IEC/2016/12/35</hrec>
      <ethicsubmitdate>23/11/2016</ethicsubmitdate>
      <ethiccountry>India</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Katherine Benfer</name>
      <address>Queensland Cerebral Palsy and Rehabilitation Research Centre
The University of Queensland
Centre for Child Health Research
Level 6, 62 Graham St
South Brisbane, QLD 4101</address>
      <phone>+91 9051997889</phone>
      <fax />
      <email>k.benfer@uq.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Katherine Benfer</name>
      <address>Queensland Cerebral Palsy and Rehabilitation Research Centre
The University of Queensland
Centre for Child Health Research
Level 6, 62 Graham St
South Brisbane, QLD 4101</address>
      <phone>+91 9051997889</phone>
      <fax />
      <email>k.benfer@uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Katherine Benfer</name>
      <address>Queensland Cerebral Palsy and Rehabilitation Research Centre
The University of Queensland
Centre for Child Health Research
Level 6, 62 Graham St
South Brisbane, QLD 4101</address>
      <phone>+91 9051997889</phone>
      <fax />
      <email>k.benfer@uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Katherine Benfer</name>
      <address>Queensland Cerebral Palsy and Rehabilitation Research Centre
The University of Queensland
Centre for Child Health Research
Level 6, 62 Graham St
South Brisbane, QLD 4101</address>
      <phone>+91 9051997889</phone>
      <fax />
      <email>k.benfer@uq.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>